Amino Acids Biostimulants and Protein Hydrolysates in Agricultural Sciences.

The effects of different types of biostimulants on crops include improving the visual quality of the final products, stimulating the immune systems of plants, inducing the biosynthesis of plant defensive biomolecules, removing heavy metals from contaminated soil, improving crop performance, reducing leaching, improving root development and seed germination, inducing tolerance to abiotic and biotic stressors, promoting crop establishment and increasing nutrient-use efficiency. Protein hydrolysates are mixtures of polypeptides and free amino acids resulting from enzymatic and chemical hydrolysis of agro-industrial protein by-products obtained from animal or plant origins, and they are able to alleviate environmental stress effects, improve growth, and promote crop productivity. Amino acids involve various advantages such as increased yield and yield components, increased nutrient assimilation and stress tolerance, and improved yield components and quality characteristics. They are generally achieved through chemical or enzymatic protein hydrolysis, with significant capabilities to influence the synthesis and activity of some enzymes, gene expression, and redox-homeostasis. Increased yield, yield components, and crop quality; improved and regulated oxidation-reduction process, photosynthesis, and physiological activities; decreased negative effects of toxic components; and improved anti-fungal activities of plants are just some of the more important benefits of the application of phenols and phenolic biostimulants. The aim of this manuscript is to survey the impacts of amino acids, different types of protein hydrolysates, phenols, and phenolic biostimulants on different plants by presenting case studies and successful paradigms in several horticultural and agricultural crops.

Treatment of Chronic Aplastic Anemia with Chinese Patent Medicine Pai-Neng-Da Capsule () for Replacing Androgen Partially: A Clinical Multi-Center Study.

OBJECTIVE: To evaluate the efficacy and safety of Pai-Neng-Da Capsule (, panaxadiol saponins component, PNDC) in combination with the cyclosporine and androgen for patients with chronic aplastic anemia (CAA). METHODS: A total of 79 CAA patients was randomly divided into 2 groups by a random number table, including PCA group [43 cases, orally PNDC 320 mg/d plus cyclosporine 5 mg/(kg·d) plus andriol 80 mg/d] and CA group [36 cases, orally cyclosporine 5 mg/(kg·d) plus andriol 160 mg/d]. All patients were treated and followed-up for 6 treatment courses over 24 weeks. The complete blood counts, score of Chinese medical (CM) symptoms were assessed and urine routine, electrocardiogram, hepatic and renal function were observed for safety evaluation. Female masculinization rating scale was established according to the actual clinical manifestations to evaluate the accurate degree of masculinization in female CAA patients treated by andriol. RESULTS: The effective rates were 88.1% (37/42) in the PCA group and 77.8% (28/36) in the CA group based on the standard for the therapeutic efficacy evaluation of hematopathy. There was no significant difference in the white blood cell (WBC) counts, platelet counts and hemoglobin concentration of peripheral blood between two groups after 6 months treatment. The masculinization score of female patient in the PCA group was significantly lower than the CA group (P<0.05). The mild abdominal distention was observed in 1 cases in the PCA group. In CA group, the abnormalities in the hepatic function developed in 2 cases and the renal disfunction was found in 1 case. CONCLUSION: The PNDC possesses certain curative effects in the treatment of CAA without obvious side-effects and can partially replace andriol thereby to reduce the degree of masculinization [Registried at Chinese Clinical Trial Registry (ChicTR1900028153)].

Coupled influence of pH and dissolved organic carbon on the immobilization of phosphorus by lanthanum-modified zeolite.

Wind-driven waves and currents in shallow lakes frequently trigger the resuspension of sediments in the photic layer, which is characterized with a high pH and high dissolved organic carbon (DOC) concentration. The mechanism of phosphorus-inactivating agents (PIAs) immobilizing phosphorus under the coupled influence of pH and DOC is not clarified, and the applicability of PIAs in eutrophic shallow lakes is thus still doubtful. We found that, under the coupled influence of pH and DOC, the uptake of phosphate by LMZ was affected mainly by pH at low DOC concentrations and by DOC at high DOC concentrations. A high pH (9.3) and high DOC concentration (24.7 mg/L) greatly increased the release of phosphorus from sediment to water. However, the addition of LMZ substantially reduced the P concentrations in water, mainly via capture of dissolved inorganic phosphorus. The results of the reversibility of the adsorption of phosphates and DOC showed that phosphate had much higher affinity than DOC towards LMZ. The phosphate once adsorbed on LMZ was resistant to release when exposed to conditions of either a high pH (9.5), high DOC concentration (250 mg/L) or both; i.e., only <5% of the adsorbed phosphate is releasable. Therefore, we proposed that, to avoid the coupled influence of pH and DOC in the photic layer of eutrophic shallow lakes, LMZ could be applied in multiple low doses in the season when the growth of algae is minimal (a low pH and low DOC concentration).

Interactions of phosphate and dissolved organic carbon with lanthanum modified bentonite: Implications for the inactivation of phosphorus in lakes.

Lanthanum-modified bentonite (LMB) is a widely used phosphorus-inactivating agent in lakes. However, dissolved organic carbon (DOC) exists ubiquitously in lakes, and its influence on phosphate binding is still not adequately understood. Our results showed that both phosphate and DOC can be adsorbed by LMB. The Langmuir adsorption maxima of phosphate and DOC were 9.06 mg P/g and 5.31 mg C/g, respectively, generating a C/P molar ratio ∼1.5. When phosphate and DOC coexisted at this ratio, the adsorption of phosphate was not influenced by DOC and vice versa. However, the phosphate capture by LMB was significantly reduced by raising the ratio above ∼9, and the reduction was increased with increasing the ratio. Once adsorbed by LMB, phosphate was essentially not desorbed by DOC, while adsorbed DOC can be mostly liberated by phosphate. It is deemed that phosphate can interact preferentially with La on LMB. However, DOC can still be adsorbed by LMB, even after LMB was saturated with phosphate, which was attributed to (i) the high coordination capacity of La; (ii) the interaction of DOC with the hydroxyl group(s) of the adsorbed phosphate via hydrogen bonding; and (iii) the interaction of DOC with the La sites unoccupied by phosphate. We proposed that LMB can be applied in the season (time) when the DOC/P ratio in lakes is low enough to facilitate the adsorption of phosphate, which will no longer be released into water, even after the C/P ratio is raised later.

The recovery of phosphorus from source-separated urine by repeatedly usable magnetic Fe3O4@ZrO2 nanoparticles under acidic conditions.

The separation of urine at source for phosphorus (P) recovery is attractive taking into account the high P concentration and small volume. However, the treatment of urine is still challenging due to its unpleasant odor and hygiene problems. Because the above problems could be solved by acidification to keep the pH of urine below 4, we propose a novel strategy to recover P from acidified urine using tailored hydrous zirconia-coated magnetite nanoparticles (Fe3O4@ZrO2). This strategy involves the selective adsorption of phosphate by easily separable and reusable Fe3O4@ZrO2, the desorption of adsorbed phosphate, and the precipitation of desorbed phosphate as calcium phosphate fertilizer. The results indicated that at pH 4, the P in synthetic urine was selectively adsorbed and could be exhausted using Fe3O4@ZrO2. Nearly all (>97.5%) of the sequestered P on the Fe3O4@ZrO2 nanoparticles was stripped using ≥1 M NaOH solution and ~100% of the stripped P was then successfully transformed into calcium phosphate, upon adding CaCl2 at pH >12 and a Ca/P molar ratio of 3. The liquid/solid (Fe3O4@ZrO2 particles) mixture could be conveniently separated for reuse using an external magnetic field. The reusability of the Fe3O4@ZrO2 nanoparticles in the extraction of P from synthetic urine was confirmed using five cycles of the adsorption-desorption process and their performance validated using real urine samples. The mechanism of phosphate adsorption was investigated using XPS, FTIR and zeta potential measurements, showing that phosphate was chemically adsorbed on the surface through direct coordination to zirconium atom via ligand exchange.

Clinical study of pai-neng-da capsule in the treatment of chronic aplastic anemia.

OBJECTIVE: To evaluate the efficacy and safety of Pai-Neng-Da Capsule (panaxadiol saponins component, PND), a new Chinese patent medicine, on patients with chronic aplastic anemia (CAA) and to explore the optimal therapeutic regimen for CAA. METHOD: A total of 36 patients with CAA were enrolled and divided into three groups: the AP group (20 cases, andriol 120 mg/day + PND 240 mg/day), the ACP group (13 cases, andriol 120 mg/day + cyclosporine 3-6 mg kd(-1) day(-1) + PND 240 mg/day), and the PND group (3 cases, PND 240 mg/day). All patients were treated and followed up for 6 months. Peripheral blood counts, renal and hepatic function and Chinese medical (CM) symptoms of patients were assessed and all indices were gathered at the beginning and end of the study. RESULT: In the AP group, no significant hematologic difference was observed at the end of 6-month treatment comparing with the beginning. In the ACP group, the blood counts were maintained at the same level after the 6-month treatment. In the PND group, trilineage hematologic improvement was displayed at the end of 6-month treatment comparing with the beginning. No significant difference was showed in renal and hepatic function in all patients. All patients' clinical symptom improved according to CM symptom score. The effective rates were 95%, 73% and 100%, respectively. CONCLUSION: PND improved the efficacy and decreased side effects by cutting down the dosage of andriol, and it could also improve patients' clinical symptom and quality of life. PND were effective and safe in the treatment of CAA, it could be used alone or in combination with pharmacological agents such as andriol and cyclosporine.